Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Yergey

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Verlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bileD A Nicoll-Griffith, N Gupta, S P Twa, et al.
Journal of the American Society for Mass Spectrometry|November 14, 2013
Enhancement of mass spectrometric detection of LTC4, LTD 4, and LTE 4 by derivatizationO A Mamer, G Just, C S Li, et al.
Archives of Biochemistry and Biophysics|November 15, 1994
Purification and characterization of recombinant human cyclooxygenase-2M D Percival, M Ouellet, C J Vincent, et al.
Epilepsia|March 1, 1990
Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizuresM P Heyes, A R Wyler, O Devinsky, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1995
In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539N Chauret, C Li, Y Ducharme, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Stable isotope-labeled tryptophan as a precursor for studying the disposition of quinolinic acid in rabbitsR L Boni, M P Heyes, J D Bacher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2001
In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatizationJ A Yergey, L A Trimble, J Silva, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2001
Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: studies with DFP, a cyclooxygenase-2 inhibitorD A Nicoll-Griffith, J M Silva, N Chauret, et al.
Brain Research|October 29, 1990
Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-DM P Heyes, M Gravell, W T London, et al.
Analytical Biochemistry|December 22, 1999
Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probeN Chauret, N Tremblay, R L Lackman, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Verlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bileD A Nicoll-Griffith, N Gupta, S P Twa, et al.
Journal of the American Society for Mass Spectrometry|November 14, 2013
Enhancement of mass spectrometric detection of LTC4, LTD 4, and LTE 4 by derivatizationO A Mamer, G Just, C S Li, et al.
Archives of Biochemistry and Biophysics|November 15, 1994
Purification and characterization of recombinant human cyclooxygenase-2M D Percival, M Ouellet, C J Vincent, et al.
Epilepsia|March 1, 1990
Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizuresM P Heyes, A R Wyler, O Devinsky, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1995
In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539N Chauret, C Li, Y Ducharme, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Stable isotope-labeled tryptophan as a precursor for studying the disposition of quinolinic acid in rabbitsR L Boni, M P Heyes, J D Bacher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2001
In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatizationJ A Yergey, L A Trimble, J Silva, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2001
Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: studies with DFP, a cyclooxygenase-2 inhibitorD A Nicoll-Griffith, J M Silva, N Chauret, et al.
Brain Research|October 29, 1990
Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-DM P Heyes, M Gravell, W T London, et al.
Analytical Biochemistry|December 22, 1999
Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probeN Chauret, N Tremblay, R L Lackman, et al.
Pageof 4